Arca
Skip to content

MSTN: Growth/differentiation factor 8

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Acts specifically as a negative regulator of skeletal muscle growth. .

  • Drugs that act on it: 7
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
ApitegromabApprovedGrowth/differentiation factor 8 inhibitorInhibitor—
Domagrozumab—Growth/differentiation factor 8 inhibitorInhibitor—
Landogrozumab—Growth/differentiation factor 8 inhibitorInhibitor—
PF-03446879—Growth/differentiation factor 8 inhibitorInhibitor—
Ramatercept—Growth/differentiation factor 8 inhibitorInhibitor—
Stamulumab—Growth/differentiation factor 8 inhibitorInhibitor—
Trevogrumab—Growth/differentiation factor 8 inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Myostatin-related muscle hypertrophy
0.50
Proximal spinal muscular atrophy
0.36
Bronchopneumonia
0.33
Lung abscess
0.33
Placenta praevia
0.16
Obesity disorder
0.13
Cancer
0.12
Obesity due to melanocortin 4 receptor deficiency
0.11

Drugs and mechanisms are from ChEMBL CHEMBL3407325 (CC BY-SA 3.0). Gene name, function (UniProt O14793, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.